Exchange: NASDAQ·Updated 08:31 AM EDT
KROS logo

KROS Keros Therapeutics Inc

$11.17
$0.00
(0.00%)
Pre-Market
Prev Close $11.17
EarningsNov 4
Mkt Cap$221.47M
Vol821.00

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
42

Bearish Sentiment

How do you feel about KROS?

Advertisement|Remove ads.